Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen: a prospective cohort study

OBJECTIVE: Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone. We evaluated efficacy of tenofovir/lamivudi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: Keene, Claire M, Griesel, Rulan, Zhao, Ying, Gcwabe, Zimasa, Sayed, Kaneez, Hill, Andrew, Cassidy, Tali, Ngwenya, Olina, Jackson, Amanda, Van Zyl, Gert, Schutz, Charlotte, Goliath, Rene, Flowers, Tracy, Goemaere, Eric, Wiesner, Lubbe, Simmons, Bryony, Maartens, Gary, Meintjes, Graeme
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7612028/
https://ncbi.nlm.nih.gov/pubmed/33973876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002936
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares